Recent Executive Leadership Changes Announced by Five Chinese Pharmaceutical Companies

Aug 08, 2024 19:45 CST Updated 19:45

Kangya

Developer, Manufacturer, and Distributor of Chemical Drug Preparations and Active Pharmaceutical Ingredients

Source: Corporate Announcement Compiled by: wangxinglai2004

Recently, five listed pharmaceutical companies announced changes in their senior management: the resignation of Beijing Konruns Pharmaceutical Co., Ltd.'s Secretary of the Board and CFO, the resignation of two Vice Presidents from Kangya of Ningxia Pharmaceutical Co., Ltd., the resignation of a Vice President from Nanjing Haichen Pharmaceutical Co., Ltd., the resignation of the financial head from Tiankang Pharmaceutical, and the resignation of the General Manager from Tianmu Mountain Pharmaceutical.

01 CFO and Secretary of the Board of Konruns Pharmaceutical Resigns

Recently, Beijing Konruns Pharmaceutical Co., Ltd. announced that the company's board of directors had received a written resignation report from Ms. Sun Yuping, the company’s secretary of the board and financial director.

Ms. Sun Yuping has applied to resign from her positions as the company's Board Secretary and Chief Financial Officer due to personal reasons. This resignation report will take effect from the date it is delivered to the Board of Directors. After stepping down from these positions, Ms. Sun Yuping will assume another role within the company. The company and the Board of Directors express their heartfelt gratitude for the contributions Ms. Sun Yuping has made to the company’s development during her tenure!

According to the relevant regulations such as the "Listing Rules of the Shanghai Stock Exchange," during the vacancy of the Board Secretary and Chief Financial Officer, the company's Board of Directors has designated Mr. Liu Jianhua, the Chairman, to act as the Board Secretary, and Mr. Liu Xiaohan, a director and General Manager of the Finance Center, to act as the Chief Financial Officer.

02 Two Deputy General Managers of Kangya Pharmaceutical Resign

Recently, Kangya of Ningxia Pharmaceutical Co., Ltd. announced that the company's board of directors received a resignation report from Vice General Manager Ms. Wu Fuhong on July 31, 2024, and her resignation became effective starting from July 31, 2024. The aforementioned resigning individual holds 98,506 shares of the company, accounting for 0.1533% of the company's equity. She is not an object of joint disciplinary action for dishonesty. After her resignation, she will assume the positions of Quality Director, Quality Head, and Pharmacovigilance Head in the company.

The company's board of directors received the resignation report submitted by Mr. Yang Yajun, the vice general manager, on July 31, 2024. The resignation took effect from July 31, 2024. The aforementioned resigning person holds 92,506 shares of the company, accounting for 0.144% of the company's equity. He is not an object of joint disciplinary action for dishonesty and will assume the position of Director of New Business Development after his resignation.

03 Vice General Manager of Nanjing Haichen Pharmaceutical Co., Ltd. Resigns

Recently, Nanjing Haichen Pharmaceutical Co., Ltd. announced that the company's board of directors received a resignation report from Vice General Manager Wei Cheng Liu. Mr. Wei Cheng Liu applied to resign from his position as vice general manager due to personal reasons.

According to the relevant provisions of the "Company Law" and the "Articles of Association," his resignation report takes effect upon delivery to the company's board of directors. After Mr. Liu Weicheng's resignation, he will no longer hold any position in the company or its subsidiaries. As of the date of this announcement, Mr. Liu Weicheng directly holds 14,000 shares of the company, accounting for 0.0117% of the total share capital.

04 Tiankang Pharmaceutical Financial Director Resigns

The board of directors of the company received the resignation report submitted by Mr. Jiang Weifeng, the financial director, on July 25, 2024. Mr. Jiang Weifeng resigned from his position as the financial director of the company due to personal reasons. The resignation took effect on July 25, 2024. The resignation of Mr. Jiang Weifeng from the position of financial director will not have an adverse impact on the production and operation of the company.

The company will complete the appointment of the financial officer as soon as possible in accordance with relevant regulations. Before the appointment of a new financial officer, Ms. Yang Jun, the senior financial manager of the company, will temporarily act as the financial officer.

05 Tianmu Mountain Pharmaceutical General Manager Resigns

Recently, Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd. announced that the company's board of directors had recently received a written resignation report from General Manager Xu Xuyu. Due to personal reasons, Mr. Xu Xuyu applied to resign from his position as the general manager of the company. After his resignation, he will still hold other positions in the company's subordinate holding subsidiaries.

According to the relevant provisions of the "Company Law" and the "Articles of Association," Mr. Xu Xuyu's resignation report takes effect from the date it is delivered to the board of directors.

The company held the third meeting of the twelfth Board of Directors on August 2, 2024, and deliberated and approved the "Proposal on the Appointment of the General Manager of the Company." Based on the nomination by the chairman of the company and the qualification review by the Nomination Committee of the Board of Directors, the Board agreed to appoint Mr. Sun Xuejian as the General Manager of the company.